Bee venom for the treatment of Parkinson's disease: How far is it possible?
- PMID: 28477460
- DOI: 10.1016/j.biopha.2017.04.065
Bee venom for the treatment of Parkinson's disease: How far is it possible?
Abstract
Parkinson's disease (PD) is the second most common neurodegenerative disease, characterized by progressive loss of dopaminergic neurons in the substantia nigra pars compacta leading to depletion of striatal dopamine and motor symptoms as bradykinesia, resting tremors, rigidity, and postural instability. Current therapeutic strategies for PD are mainly symptomatic and may cause motor complications, such as motor fluctuations and dyskinesia. Therefore, alternative medicine may offer an effective adjuvant treatment for PD. Bee venom therapy (BVT) has long been used as a traditional therapy for several conditions, such as rheumatoid arthritis, asthma, and skin diseases. Experimental and clinical studies showed that BVT could be an effective adjuvant treatment for PD. Several mechanisms were suggested for these findings including the ability of BVT to attenuate neuroinflammation, inhibit apoptosis of dopaminergic neurons, protect against glutamate-induced neurotoxicity, and restore normal dopamine levels in the nigrostriatal pathway. In this article, we reviewed and summarized the literature regarding the potential of BVT for the treatment of PD.
Keywords: Bee venom; Complementary therapies; Dopaminergic neurons; Parkinson's disease.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease.PLoS One. 2015 Nov 16;10(11):e0142838. doi: 10.1371/journal.pone.0142838. eCollection 2015. PLoS One. 2015. PMID: 26571268 Free PMC article.
-
Effects of bee venom and dopamine-loaded nanoparticles on reserpine-induced Parkinson's disease rat model.Sci Rep. 2021 Oct 27;11(1):21141. doi: 10.1038/s41598-021-00764-y. Sci Rep. 2021. PMID: 34707203 Free PMC article.
-
Neuroprotective and Therapeutic Strategies against Parkinson's Disease: Recent Perspectives.Int J Mol Sci. 2016 Jun 8;17(6):904. doi: 10.3390/ijms17060904. Int J Mol Sci. 2016. PMID: 27338353 Free PMC article. Review.
-
Bee venom protects SH-SY5Y human neuroblastoma cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death.Brain Res. 2012 Jan 6;1429:106-15. doi: 10.1016/j.brainres.2011.10.003. Epub 2011 Oct 6. Brain Res. 2012. PMID: 22078207
-
Disease modification in Parkinson's disease.Drugs Aging. 2011 Aug 1;28(8):605-15. doi: 10.2165/11591320-000000000-00000. Drugs Aging. 2011. PMID: 21812497 Review.
Cited by
-
Comparison of Metabolites and Gut Microbes between Patients with Parkinson's Disease and Healthy Individuals-A Pilot Clinical Observational Study (STROBE Compliant).Healthcare (Basel). 2022 Feb 4;10(2):302. doi: 10.3390/healthcare10020302. Healthcare (Basel). 2022. PMID: 35206916 Free PMC article.
-
Comparison of the Protective Effects of Bee Venom Extracts with Varying PLA2 Compositions in a Mouse Model of Parkinson's Disease.Toxins (Basel). 2019 Jun 19;11(6):358. doi: 10.3390/toxins11060358. Toxins (Basel). 2019. PMID: 31248167 Free PMC article.
-
Apitherapy for Parkinson's Disease: A Focus on the Effects of Propolis and Royal Jelly.Oxid Med Cell Longev. 2020 Oct 17;2020:1727142. doi: 10.1155/2020/1727142. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 33123309 Free PMC article. Review.
-
Animal protein toxins: origins and therapeutic applications.Biophys Rep. 2018;4(5):233-242. doi: 10.1007/s41048-018-0067-x. Epub 2018 Oct 11. Biophys Rep. 2018. PMID: 30533488 Free PMC article.
-
Therapeutic Potential of Bee and Scorpion Venom Phospholipase A2 (PLA2): A Narrative Review.Iran J Med Sci. 2022 Jul;47(4):300-313. doi: 10.30476/IJMS.2021.88511.1927. Iran J Med Sci. 2022. PMID: 35919080 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
